These are just some of the reasons to invest in translational medicine in Scotland.
- Leading international researchers;
- translational and clinical science expertise;
- a centralised healthcare system;
- collaboration opportunities; and
- state of the art research facilities
In harnessing the collaborative abilities of world-class research and clinical expertise, Scotland has emerged as a global leader in the field of translational medicine. The country has a proven ability to deliver large and complex collaborative translational projects that meet research, clinical and commercial objectives in multiple key diseases.
Scotland is the partner that can offer faster and more effective progress from “bench to bedside”.
Translational Medicine research in Scotland
The Translational Medicine Research Collaboration is a partnership between US pharmaceutical giant Wyeth, four Scottish universities, NHS Scotland and Scottish Enterprise. The collaboration is a world first in translational medicine, combining commercial, clinical and academic expertise to improve understanding of a wide range of diseases.
Scottish Academic Health Sciences Collaboration (SAHSC)
SAHSC establishes a world leading clinical research platform for patient oriented research. It builds on the close NHS Scotland and academic partnerships already existing in Aberdeen, Dundee, Edinburgh and Glasgow and through these to other Scottish Health Boards and universities.
Key areas of translational medicine research in Scotland include:
- Oncology;
- Metabolism (diabetes);
- Inflammation, autoimmune and bone;
- Central Nervous System (CNS); and
- Virology
Find more information on SAHSC at the Life Sciences Scotland website
Translational Medicine in Scotland – infrastructure
The Scottish life science sector is well served through the construction of purpose-built clinical facilities and superbly equipped laboratories. Whether you are starting a new translational medicine business, or looking for a major company location, Scotland has a property to suit your requirements.
Edinburgh BioQuarter
A key development is the £600 million Edinburgh BioQuarter, the only area in the UK that offers the co-location of academic, clinical and commercial facilities. This supports Scotland’s expertise in translational medicine and positions Edinburgh as one of the world’s foremost centres for biomedical research and development.
- Scotland provides a highly supportive and attractive regulatory environment for life science companies to innovate and research.
- Numerous government-supported incubators and science parks are available, as are funding packages.
- Scotland has an established network of over 65 pharmaceutical clinical trials support and contract research organisations.
- There is a thriving specialist life sciences specialist manufacturing community.
- A unique, integrated bioinformatics research community is recognised for its excellence in academia and industry worldwide.
Contact us to learn more about the opportunities for investment in the Scottish translational medicine industry and the support we offer all life science sectors in Scotland.